Skip to main navigation
Menu
About RedHill
Company Profile
Management Team
Board of Directors
Advisory Board
Products
Commercial Products
Donnatal®
EnteraGam®
Development Pipeline
Pipeline Overview
TALICIA™
(H. pylori)
RHB-104 (GI/Inflammation)
Crohn's disease
Multiple Sclerosis
Rheumatoid Arthritis
BEKINDA® (GI)
Gastroenteritis & Gastritis
IBS-D
RHB-106 (GI)
YELIVA® (Oncology)
MESUPRON (Oncology)
RIZAPORT® (Migraine)
Expanded Access Program
Partnering
Investors
PRESS RELEASES
EVENTS & PRESENTATIONS
SEC FILINGS AND FINANCIAL INFORMATION
STOCK INFORMATION
ANALYST INFORMATION
CORPORATE GOVERNANCE
CONTACT US
News
2018
2017
2016
2015
2014
2013
Contact
CAREERS
Home
//
Investors
//
Events & Presentations
//
BIO CEO & Investor Conference
BIO CEO & Investor Conference
Feb 11 - 12, 2019
Location:
New York Marriott Marquis
Remind Me
Investor Relations
Press Releases
Events & Presentations
SEC Filings and Financial Information
Stock Information
Analyst Information
Corporate Governance
Contact Us
Investor Tools
Email Alerts Subscription
Download Library
Snapshot
RSS News Feeds
Print
Share
Facebook
Google
LinkedIn
Twitter
RSS
Close
